Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HR-HPV Multi-site Opportunistic Screening in Liaoning, China

NCT03178136 is registered in ClinicalTrials.gov with Min Wang as lead sponsor.

NCT NCT03178136
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03178136 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HR-HPV Multi-site Opportunistic Screening in Liaoning, China
Lead sponsor
Min Wang
Phase
Observational
Overall status
Unknown status
Start date
June 19, 2017
Completion date
June 30, 2022
Enrollment
10,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer